• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CSL Recalls Remaining Supplies of Panvax citing decline of Potency - A/H1N1 Vaccine

sharon sanders

Editor-in-Chief & President
received via email -


CSL to Retrieve Kids? Swine Flu Vaccine After Halving Shelf Life
2010-08-26 03:14:32.481 GMT


By Simeon Bennett
Aug. 26 (Bloomberg) -- CSL Ltd., the only flu vaccine
manufacturer in the Southern Hemisphere, is recalling all
remaining supplies in Australia of its Panvax Junior swine flu
shot for children after cutting the product?s shelf life.
Unused doses can be considered expired after the shelf life
was reduced to 6 months from 12 months, Melbourne-based CSL said
in a statement on its website today. CSL cited a decline in the
potency of the vaccine for the recommendation.

Link to Company News:{CSL AU <Equity> CN <GO>}

For Related News and Information:
Top Stories:{TOP<GO>}

To contact the reporter on this story:
Simeon Bennett in Singapore at +65-6212-1574 or
sbennett9@bloomberg.net

To contact the editor responsible for this story:
Jason Gale at +65-6212-1579 or
j.gale@bloomberg.net

</pre>
 
Back
Top